What are the uses and dosages of Clonidine (clonidine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clonidine: Clinical Uses and Dosing

Primary Indications

Clonidine is FDA-approved primarily for hypertension, with off-label uses including ADHD (particularly as a second-line non-stimulant option), anxiety disorders, PTSD-associated nightmares, and opioid withdrawal management. 1

Hypertension (FDA-Approved)

For hypertension, start with 0.1 mg twice daily (morning and bedtime), with weekly increases of 0.1 mg/day as needed until blood pressure is controlled. 1

  • Therapeutic doses typically range from 0.2-0.6 mg/day in divided doses 1
  • Maximum effective daily dose is 2.4 mg, though doses this high are rarely needed 1
  • Elderly patients should start at lower initial doses 1
  • Taking the larger portion at bedtime minimizes dry mouth and drowsiness 1

For hypertensive urgencies/emergencies, oral clonidine loading can achieve rapid blood pressure control: start with 0.1-0.2 mg, followed by 0.05-0.1 mg hourly until goal blood pressure is reached or a total of 0.7-0.8 mg is given. 2, 3 This achieves successful blood pressure reduction in 93% of patients within 1-2 hours. 3

ADHD (Off-Label, Second-Line)

Clonidine functions as a non-stimulant option for ADHD through alpha-2 adrenergic receptor agonism, providing "around-the-clock" effects but with smaller effect sizes compared to stimulants. 4

  • Particularly useful as first-line when comorbid sleep disorders, substance use disorders, disruptive behavior disorders, or tic/Tourette's disorder are present 4
  • Requires 2-4 weeks until therapeutic effects are observed 4
  • Twice-daily dosing is necessary for immediate-release formulations 4
  • Transdermal patches are available for more consistent delivery 4
  • Can be used to augment stimulant treatment 4

Anxiety and PTSD

For anxiety, initiate at 0.05-0.1 mg at bedtime to minimize side effects, gradually increasing to 0.1 mg 2-3 times daily, with a maximum of 0.4 mg/day. 5

  • For PTSD-associated nightmares specifically, doses of 0.2-0.6 mg in divided doses have demonstrated efficacy 5
  • Clonidine acts as a central alpha-2 agonist that suppresses sympathetic nervous system outflow, producing anxiolytic effects 5

Opioid Withdrawal

Clonidine helps manage withdrawal symptoms during opioid tapering, though specific dosing protocols are not clearly established in guidelines. 5

Formulations and Bioequivalence

  • Oral tablets: 0.1-0.8 mg daily, typically divided into two doses 6
  • Transdermal patches: Provide steady-state plasma concentrations by day 4, with maximum blood pressure reduction occurring 2-3 days after application and maintained for 7 days 7
  • The transdermal system releases drug proportional to surface area, with the smallest system being 3.5 cm² 7

Critical Safety Monitoring

Never discontinue clonidine abruptly—this can precipitate hypertensive crisis with rebound hypertension; always taper the medication. 5, 8

  • Monitor pulse and blood pressure regularly 4, 5, 8
  • Common side effects include orthostatic hypotension, drowsiness, dry mouth, and sedation 5, 8
  • Clonidine is generally reserved as a last-line antihypertensive agent in older adults due to significant CNS adverse effects 5, 8
  • In ADHD treatment, monitor for somnolence/sedation (evening administration is preferable) 4
  • For ADHD in children, also monitor suicidality and clinical worsening 4

Special Populations

Patients with renal impairment should start at lower doses with careful monitoring, though hemodialysis does not require supplemental dosing. 1

Clonidine is primarily metabolized via CYP2D6, which may affect dosing in patients with genetic polymorphisms or drug interactions. 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Clonidine Dosage and Administration for Anxiety

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Clonidine Pharmacokinetics and Bioavailability

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical pharmacokinetics of clonidine.

Clinical pharmacokinetics, 1988

Guideline

Clonidine Transdermal Patch Administration and Monitoring

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.